Patient-Centered Approaches to Treatment and Prevention of Clostridioides difficile Infection
| Overview / Abstract: |
Listen in as two patients share their experiences with treatment for C. difficile and its recurrence. In this short webisode Dr. Paul Feuerstadt and Dr. Sahil Khanna discuss fresh insights and strategies for selecting treatment of CDI in real-world settings. The Centers for Disease Control and Prevention continues to classify C. difficile as an urgent threat given the great burden on patients and the healthcare system. This Gram-positive bacterium causes diarrhea, abdominal bloating, and colitis in addition to significant morbidity and mortality, increased healthcare costs, and hospital readmission rates. In response to accumulating clinical trial evidence and real-world data, guideline recommendations on the selection of antimicrobial therapy have changed. Clinicians may not be familiar with these changes in the selection and application of antimicrobial therapies for treating initial and recurrent CDI. |
|
Expiration |
May 09, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
.75 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Paul Feuerstadt, MD, FACG, AGAF Sahil Khanna, MBBS, MS, FACG |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Merck & Co., Inc.. |
|
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Newsletter, C. difficile, CME, ACG, Dr. Feuerstadt, Dr. Khanna, gut microbiome, recurrent, infections, infectious disease, gastroenterology, physician, pharmacists, live symposium, microbiota restoration therapy, fidaxomicin, IDSA/SHEA, bezlotoxumab, vancomycin, webisodes Free CE CME |
|